1612 — Vincent Medical Holdings Income Statement
0.000.00%
- HK$251.53m
- HK$182.55m
- HK$800.96m
- 83
- 99
- 73
- 98
Annual income statement for Vincent Medical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,155 | 778 | 629 | 718 | 801 |
Cost of Revenue | |||||
Gross Profit | 494 | 259 | 165 | 240 | 260 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 863 | 703 | 640 | 652 | 721 |
Operating Profit | 292 | 74.5 | -11 | 65.8 | 79.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 284 | 66.2 | -15.5 | 66.9 | 78 |
Provision for Income Taxes | |||||
Net Income After Taxes | 247 | 60.1 | -18.4 | 58.2 | 70.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 217 | 60.7 | -17.4 | 57.3 | 69.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 217 | 60.7 | -17.4 | 57.3 | 69.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.348 | 0.111 | -0.022 | 0.09 | 0.111 |
Dividends per Share | |||||
Special Dividends per Share |